IBDEI0Y2 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16584,1,4,0)
 ;;=4^Cirrohosis
 ;;^UTILITY(U,$J,358.3,16585,0)
 ;;=790.6^^84^990^1
 ;;^UTILITY(U,$J,358.3,16585,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16585,1,3,0)
 ;;=3^790.6
 ;;^UTILITY(U,$J,358.3,16585,1,4,0)
 ;;=4^Abnormal LFT's
 ;;^UTILITY(U,$J,358.3,16585,2)
 ;;=^87228
 ;;^UTILITY(U,$J,358.3,16586,0)
 ;;=070.1^^84^990^5
 ;;^UTILITY(U,$J,358.3,16586,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16586,1,3,0)
 ;;=3^070.1
 ;;^UTILITY(U,$J,358.3,16586,1,4,0)
 ;;=4^Hepatitis A w/o Coma
 ;;^UTILITY(U,$J,358.3,16586,2)
 ;;=^126486
 ;;^UTILITY(U,$J,358.3,16587,0)
 ;;=070.30^^84^990^6
 ;;^UTILITY(U,$J,358.3,16587,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16587,1,3,0)
 ;;=3^070.30
 ;;^UTILITY(U,$J,358.3,16587,1,4,0)
 ;;=4^Hepatitis B w/o Coma or Delta
 ;;^UTILITY(U,$J,358.3,16587,2)
 ;;=^266626
 ;;^UTILITY(U,$J,358.3,16588,0)
 ;;=V02.62^^84^990^7
 ;;^UTILITY(U,$J,358.3,16588,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16588,1,3,0)
 ;;=3^V02.62
 ;;^UTILITY(U,$J,358.3,16588,1,4,0)
 ;;=4^Hepatitis C Carrier
 ;;^UTILITY(U,$J,358.3,16588,2)
 ;;=^317947
 ;;^UTILITY(U,$J,358.3,16589,0)
 ;;=070.51^^84^990^2
 ;;^UTILITY(U,$J,358.3,16589,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16589,1,3,0)
 ;;=3^070.51
 ;;^UTILITY(U,$J,358.3,16589,1,4,0)
 ;;=4^Acute Hepatitis C w/o Coma
 ;;^UTILITY(U,$J,358.3,16589,2)
 ;;=^331778
 ;;^UTILITY(U,$J,358.3,16590,0)
 ;;=070.54^^84^990^3
 ;;^UTILITY(U,$J,358.3,16590,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16590,1,3,0)
 ;;=3^070.54
 ;;^UTILITY(U,$J,358.3,16590,1,4,0)
 ;;=4^Chr Hepatitis C w/o Coma
 ;;^UTILITY(U,$J,358.3,16590,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,16591,0)
 ;;=070.70^^84^990^8
 ;;^UTILITY(U,$J,358.3,16591,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16591,1,3,0)
 ;;=3^070.70
 ;;^UTILITY(U,$J,358.3,16591,1,4,0)
 ;;=4^Hepatitis C w/o Coma,Unspec
 ;;^UTILITY(U,$J,358.3,16591,2)
 ;;=^331436
 ;;^UTILITY(U,$J,358.3,16592,0)
 ;;=340.^^84^991^4
 ;;^UTILITY(U,$J,358.3,16592,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16592,1,3,0)
 ;;=3^340.
 ;;^UTILITY(U,$J,358.3,16592,1,4,0)
 ;;=4^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,16593,0)
 ;;=435.9^^84^991^6
 ;;^UTILITY(U,$J,358.3,16593,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16593,1,3,0)
 ;;=3^435.9
 ;;^UTILITY(U,$J,358.3,16593,1,4,0)
 ;;=4^TIA
 ;;^UTILITY(U,$J,358.3,16594,0)
 ;;=356.9^^84^991^5
 ;;^UTILITY(U,$J,358.3,16594,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16594,1,3,0)
 ;;=3^356.9
 ;;^UTILITY(U,$J,358.3,16594,1,4,0)
 ;;=4^Periperal Neuropathy
 ;;^UTILITY(U,$J,358.3,16594,2)
 ;;=Peripheral Neuropathy^123931
 ;;^UTILITY(U,$J,358.3,16595,0)
 ;;=434.91^^84^991^1
 ;;^UTILITY(U,$J,358.3,16595,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16595,1,3,0)
 ;;=3^434.91
 ;;^UTILITY(U,$J,358.3,16595,1,4,0)
 ;;=4^Acute Stroke
 ;;^UTILITY(U,$J,358.3,16595,2)
 ;;=^295738
 ;;^UTILITY(U,$J,358.3,16596,0)
 ;;=V12.54^^84^991^3
 ;;^UTILITY(U,$J,358.3,16596,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16596,1,3,0)
 ;;=3^V12.54
 ;;^UTILITY(U,$J,358.3,16596,1,4,0)
 ;;=4^HX of Stroke w/o Residuals
 ;;^UTILITY(U,$J,358.3,16596,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,16597,0)
 ;;=294.20^^84^991^2
 ;;^UTILITY(U,$J,358.3,16597,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16597,1,3,0)
 ;;=3^294.20
 ;;^UTILITY(U,$J,358.3,16597,1,4,0)
 ;;=4^Dementia
 ;;^UTILITY(U,$J,358.3,16597,2)
 ;;=^340607
 ;;^UTILITY(U,$J,358.3,16598,0)
 ;;=692.9^^84^992^2
 ;;^UTILITY(U,$J,358.3,16598,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16598,1,3,0)
 ;;=3^692.9
 ;;^UTILITY(U,$J,358.3,16598,1,4,0)
 ;;=4^Contact Dermatitis
 ;;^UTILITY(U,$J,358.3,16599,0)
 ;;=682.9^^84^992^1
 ;;
 ;;$END ROU IBDEI0Y2
